Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Begum, DB"'
Autor:
Shah, V, Sherborne, AL, Walker, BA, Johnson, DC, Boyle, EM, Ellis, S, Begum, DB, Proszek, PZ, Jones, JR, Pawlyn, C, Savola, S, Jenner, MW, Drayson, MT, Owen, RG, Houlston, RS, Cairns, DA, Gregory, WM, Cook, G, Davies, F, Jackson, GH, Morgan, GJ, Kaiser, MF
Robust establishment of survival in multiple myeloma (MM) and its relationship to recurrent genetic aberrations is required as outcomes are variable despite apparent similar staging. We assayed copy number alterations (CNA) and translocations in 1036
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::85ee3ae844525eae55a5c49d73e065df
https://eprints.whiterose.ac.uk/117302/16/leu2017179a.pdf
https://eprints.whiterose.ac.uk/117302/16/leu2017179a.pdf
Autor:
Johnson, DC, Weinhold, N, Mitchell, JS, Chen, B, Kaiser, M, Begum, DB, Hillengass, J, Bertsch, U, Gregory, WA, Cairns, D, Jackson, GH, Försti, A, Nickel, J, Hoffmann, P, Nöethen, MM, Stephens, OW, Barlogie, B, Davis, FE, Hemminki, K, Goldschmidt, H, Houlston, RS, Morgan, GJ
Publikováno v:
Nature Communications
Survival following a diagnosis of multiple myeloma (MM) varies between patients and some of these differences may be a consequence of inherited genetic variation. In this study, to identify genetic markers associated with MM overall survival (MM-OS),
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::e09f96198b35a956099b9a32a07f1911
https://eprints.whiterose.ac.uk/94466/1/ncomms10290.pdf
https://eprints.whiterose.ac.uk/94466/1/ncomms10290.pdf
Autor:
Nicola E. Potter, Brian A Walker, Faith E. Davies, Michele Cavo, Annamaria Brioli, Lorenzo Melchor, Gowri Vijayaraghavan, Alex Murison, Dil B Begum, S. Hulkki Wilson, Rosemary A Fryer, Martin Kaiser, Ian Titley, Christopher P. Wardell, David W. Johnson, Gareth J. Morgan
Publikováno v:
Leukemia. 28(8)
Although intratumor heterogeneity has been inferred in multiple myeloma (MM), little is known about its subclonal phylogeny. To describe such phylogenetic trees in a series of patients with MM, we perform whole-exome sequencing and single-cell geneti
Autor:
Brian A Walker, Christopher P. Wardell, David W. Johnson, Martin Kaiser, Nasrin Dahir, Eileen M Boyle, Fiona M. Ross, Faith E. Davies, Annamaria Brioli, Gareth J. Morgan, Dil B Begum
Publikováno v:
Blood Cancer Journal
Secondary MYC translocations in myeloma have been shown to be important in the pathogenesis and progression of disease. Here, we have used a DNA capture and massively parallel sequencing approach to identify the partner chromosomes in 104 presentatio
Autor:
Golgeri M DB; Department of Biochemistry, School of Allied Health Sciences, REVA University, Bangalore, India.; Department of Biochemistry, Indian Academy Degree College-Autonomous Kalyanagar, Bangalore, India., Mulla SI; Department of Biochemistry, School of Allied Health Sciences, REVA University, Bangalore, India., Bagewadi ZK; Department of Biotechnology, KLE Technological University, Hubballi, Karnataka, India., Tyagi S; IRRI- South Asia Regional centre, Varanasi, Uttar Pradesh, India., Hu A; Institute of Urban Environment Chinese Academy of Sciences, CAS Key Laboratory of Urban Pollutant Conversion, Xiamen, China., Sharma S; University Institute of Biotechnology (UIBT), Chandigarh University, Mohali, Punjab, India., Bilal M; School of Life Science and Food Engineering, Huaiyin Institute of Technology, Huaian, China., Bharagava RN; Department of Microbiology (DM), School for Environmental Sciences (SES), Babasaheb Bhimrao Ambedkar University (A Central University), Lucknow, Uttar Pradesh, India., Ferreira LFR; Graduate Program in Process Engineering, Tiradentes University, Farolândia, Aracaju-SE, Brazil., Gurumurthy DM; Department of Microbiology and Immunology, Montana State University, Bozeman, USA., Nadda AK; Department of Biotechnology and Bioinformatics, Jaypee University of Information Technology, Waknaghat, Solan, Himachal Pradesh, India.
Publikováno v:
Critical reviews in food science and nutrition [Crit Rev Food Sci Nutr] 2024; Vol. 64 (2), pp. 438-455. Date of Electronic Publication: 2022 Aug 05.
Autor:
Jones JR; Department of Haematology, The Royal Marsden Hospital NHS Foundation Trust, London, UK.; The Institute of Cancer Research, London, UK., Weinhold N; Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA., Ashby C; Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA., Walker BA; Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA., Wardell C; Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA., Pawlyn C; Department of Haematology, The Royal Marsden Hospital NHS Foundation Trust, London, UK.; The Institute of Cancer Research, London, UK., Rasche L; Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA., Melchor L; The Institute of Cancer Research, London, UK., Cairns DA; Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, UK., Gregory WM; Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, UK., Johnson D; The Institute of Cancer Research, London, UK., Begum DB; The Institute of Cancer Research, London, UK., Ellis S; The Institute of Cancer Research, London, UK., Sherborne AL; Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA., Cook G; Leeds Institute of Cancer and Pathology, University of Leeds, UK., Kaiser MF; Department of Haematology, The Royal Marsden Hospital NHS Foundation Trust, London, UK.; The Institute of Cancer Research, London, UK., Drayson MT; Clinical Immunology, School of Immunity and Infection, University of Birmingham, UK., Owen RG; Leeds Institute of Cancer and Pathology, University of Leeds, UK., Jackson GH; Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, UK., Davies FE; Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA., Greaves M; The Institute of Cancer Research, London, UK., Morgan GJ; Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA gjmorgan@uams.edu.
Publikováno v:
Haematologica [Haematologica] 2019 Jul; Vol. 104 (7), pp. 1440-1450. Date of Electronic Publication: 2019 Feb 07.
Autor:
Shah V; Division of Molecular Pathology, The Institute of Cancer Research, London, UK., Sherborne AL; Division of Molecular Pathology, The Institute of Cancer Research, London, UK., Walker BA; MIRT, University of Arkansas for Medical Sciences, Little Rock, AR, USA., Johnson DC; Division of Molecular Pathology, The Institute of Cancer Research, London, UK., Boyle EM; Department of Haematology, Hopital Huriez, CHRU, Lille, France., Ellis S; Division of Molecular Pathology, The Institute of Cancer Research, London, UK., Begum DB; Division of Molecular Pathology, The Institute of Cancer Research, London, UK., Proszek PZ; Division of Molecular Pathology, The Institute of Cancer Research, London, UK., Jones JR; Division of Molecular Pathology, The Institute of Cancer Research, London, UK., Pawlyn C; Division of Molecular Pathology, The Institute of Cancer Research, London, UK., Savola S; MRC Holland, Amsterdam, The Netherlands., Jenner MW; Department of Haematology, University Hospital Southampton, Southampton, UK., Drayson MT; Clinical Immunology, School of Immunity & Infection, University of Birmingham, Birmingham, UK., Owen RG; Department of Haematology, St James's University Hospital, Leeds, UK., Houlston RS; Division of Molecular Pathology, The Institute of Cancer Research, London, UK., Cairns DA; Clinical Trials Research Unit, University of Leeds, Leeds, UK., Gregory WM; Clinical Trials Research Unit, University of Leeds, Leeds, UK., Cook G; Section of Experimental Haematology, Leeds Institute of Cancer & Pathology, University of Leeds, Leeds, UK., Davies FE; MIRT, University of Arkansas for Medical Sciences, Little Rock, AR, USA., Jackson GH; Department of Haematology, Newcastle University, Newcastle upon Tyne, UK., Morgan GJ; MIRT, University of Arkansas for Medical Sciences, Little Rock, AR, USA., Kaiser MF; Division of Molecular Pathology, The Institute of Cancer Research, London, UK.
Publikováno v:
Leukemia [Leukemia] 2018 Jan; Vol. 32 (1), pp. 102-110. Date of Electronic Publication: 2017 Jun 06.
Autor:
Pawlyn C; The Institute of Cancer Research, London, United Kingdom., Kaiser MF; The Institute of Cancer Research, London, United Kingdom., Heuck C; Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, Arkansas., Melchor L; The Institute of Cancer Research, London, United Kingdom., Wardell CP; The Institute of Cancer Research, London, United Kingdom., Murison A; The Institute of Cancer Research, London, United Kingdom., Chavan SS; Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, Arkansas., Johnson DC; The Institute of Cancer Research, London, United Kingdom., Begum DB; The Institute of Cancer Research, London, United Kingdom., Dahir NM; The Institute of Cancer Research, London, United Kingdom., Proszek PZ; The Institute of Cancer Research, London, United Kingdom., Cairns DA; Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, United Kingdom., Boyle EM; The Institute of Cancer Research, London, United Kingdom., Jones JR; The Institute of Cancer Research, London, United Kingdom., Cook G; University of Leeds, Leeds, United Kingdom., Drayson MT; Clinical Immunology, School of Immunity and Infection, University of Birmingham, Birmingham, United Kingdom., Owen RG; St James's University Hospital, Leeds, United Kingdom., Gregory WM; Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, United Kingdom., Jackson GH; Department of Haematology, Newcastle University, Newcastle, United Kingdom., Barlogie B; Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, Arkansas., Davies FE; The Institute of Cancer Research, London, United Kingdom.; Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, Arkansas., Walker BA; The Institute of Cancer Research, London, United Kingdom.; Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, Arkansas., Morgan GJ; The Institute of Cancer Research, London, United Kingdom. GJMorgan@uams.edu.; Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, Arkansas.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2016 Dec 01; Vol. 22 (23), pp. 5783-5794. Date of Electronic Publication: 2016 May 27.
Autor:
Johnson DC; Division of Molecular Pathology, The Institute of Cancer Research, London SW7 3RP, UK., Weinhold N; Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205, USA.; Department of Internal Medicine V, University of Heidelberg, 69120 Heidelberg, Germany., Mitchell JS; Division of Genetics and Epidemiology, The Institute of Cancer Research, London SW7 3RP, UK., Chen B; German Cancer Research Center, 69121 Heidelberg, Germany., Kaiser M; Division of Molecular Pathology, The Institute of Cancer Research, London SW7 3RP, UK., Begum DB; Division of Molecular Pathology, The Institute of Cancer Research, London SW7 3RP, UK., Hillengass J; Department of Internal Medicine V, University of Heidelberg, 69120 Heidelberg, Germany., Bertsch U; Department of Internal Medicine V, University of Heidelberg, 69120 Heidelberg, Germany., Gregory WA; Leeds Institute of Molecular Medicine, Section of Clinical Trials Research, University of Leeds, Leeds LS2 9PH, UK., Cairns D; Leeds Institute of Molecular Medicine, Section of Clinical Trials Research, University of Leeds, Leeds LS2 9PH, UK., Jackson GH; Department of Haematology, Newcastle University, Newcastle-upon-Tyne NE1 7RU, UK., Försti A; German Cancer Research Center, 69121 Heidelberg, Germany.; Center for Primary Health Care Research, Lund University, 221 00 Malmö, Sweden., Nickel J; Department of Internal Medicine V, University of Heidelberg, 69120 Heidelberg, Germany., Hoffmann P; Institute of Human Genetics, University of Bonn, D-53127 Bonn, Germany.; Division of Medical Genetics, Department of Biomedicine, University of Basel, 4031 Basel, Switzerland., Nöethen MM; Institute of Human Genetics, University of Bonn, D-53127 Bonn, Germany.; Department of Genomics, Life &Brain Center, University of Bonn, D-53127 Bonn, Germany., Stephens OW; Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205, USA., Barlogie B; Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205, USA., Davis FE; Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205, USA., Hemminki K; German Cancer Research Center, 69121 Heidelberg, Germany.; Center for Primary Health Care Research, Lund University, 221 00 Malmö, Sweden., Goldschmidt H; Department of Internal Medicine V, University of Heidelberg, 69120 Heidelberg, Germany.; National Center of Tumor Diseases, 69120 Heidelberg, Germany., Houlston RS; Division of Molecular Pathology, The Institute of Cancer Research, London SW7 3RP, UK.; Division of Genetics and Epidemiology, The Institute of Cancer Research, London SW7 3RP, UK., Morgan GJ; Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205, USA.
Publikováno v:
Nature communications [Nat Commun] 2016 Jan 08; Vol. 7, pp. 10290. Date of Electronic Publication: 2016 Jan 08.
Autor:
Walker BA; Brian A. Walker, Eileen M. Boyle, Christopher P. Wardell, Alex Murison, Dil B. Begum, Nasrin M. Dahir, Paula Z. Proszek, David C. Johnson, Martin F. Kaiser, Lorenzo Melchor, Lauren I. Aronson, Charlotte Pawlyn, Fabio Mirabella, John R. Jones, Annamaria Brioli, Faith E. Davies, and Gareth J. Morgan, The Institute of Cancer Research, London; Matthew Scales, The Institute of Cancer Research, Surrey; David A. Cairns, Walter M. Gregory, and Ana Quartilho, University of Leeds; Gordon Cook, St James's University Hospital, Leeds; Mark T. Drayson, University of Birmingham, Birmingham; Nigel Russell, Nottingham University Hospital, Nottingham; Graham H. Jackson, Newcastle University, Newcastle upon Tyne, United Kingdom; Aneta Mikulasova, Masaryk University, Brno, Czech Republic; and Xavier Leleu, Hôpital C. Huriez, Centre Hospitalier Régional Universitaire de Lille, Lille, France., Boyle EM; Brian A. Walker, Eileen M. Boyle, Christopher P. Wardell, Alex Murison, Dil B. Begum, Nasrin M. Dahir, Paula Z. Proszek, David C. Johnson, Martin F. Kaiser, Lorenzo Melchor, Lauren I. Aronson, Charlotte Pawlyn, Fabio Mirabella, John R. Jones, Annamaria Brioli, Faith E. Davies, and Gareth J. Morgan, The Institute of Cancer Research, London; Matthew Scales, The Institute of Cancer Research, Surrey; David A. Cairns, Walter M. Gregory, and Ana Quartilho, University of Leeds; Gordon Cook, St James's University Hospital, Leeds; Mark T. Drayson, University of Birmingham, Birmingham; Nigel Russell, Nottingham University Hospital, Nottingham; Graham H. Jackson, Newcastle University, Newcastle upon Tyne, United Kingdom; Aneta Mikulasova, Masaryk University, Brno, Czech Republic; and Xavier Leleu, Hôpital C. Huriez, Centre Hospitalier Régional Universitaire de Lille, Lille, France., Wardell CP; Brian A. Walker, Eileen M. Boyle, Christopher P. Wardell, Alex Murison, Dil B. Begum, Nasrin M. Dahir, Paula Z. Proszek, David C. Johnson, Martin F. Kaiser, Lorenzo Melchor, Lauren I. Aronson, Charlotte Pawlyn, Fabio Mirabella, John R. Jones, Annamaria Brioli, Faith E. Davies, and Gareth J. Morgan, The Institute of Cancer Research, London; Matthew Scales, The Institute of Cancer Research, Surrey; David A. Cairns, Walter M. Gregory, and Ana Quartilho, University of Leeds; Gordon Cook, St James's University Hospital, Leeds; Mark T. Drayson, University of Birmingham, Birmingham; Nigel Russell, Nottingham University Hospital, Nottingham; Graham H. Jackson, Newcastle University, Newcastle upon Tyne, United Kingdom; Aneta Mikulasova, Masaryk University, Brno, Czech Republic; and Xavier Leleu, Hôpital C. Huriez, Centre Hospitalier Régional Universitaire de Lille, Lille, France., Murison A; Brian A. Walker, Eileen M. Boyle, Christopher P. Wardell, Alex Murison, Dil B. Begum, Nasrin M. Dahir, Paula Z. Proszek, David C. Johnson, Martin F. Kaiser, Lorenzo Melchor, Lauren I. Aronson, Charlotte Pawlyn, Fabio Mirabella, John R. Jones, Annamaria Brioli, Faith E. Davies, and Gareth J. Morgan, The Institute of Cancer Research, London; Matthew Scales, The Institute of Cancer Research, Surrey; David A. Cairns, Walter M. Gregory, and Ana Quartilho, University of Leeds; Gordon Cook, St James's University Hospital, Leeds; Mark T. Drayson, University of Birmingham, Birmingham; Nigel Russell, Nottingham University Hospital, Nottingham; Graham H. Jackson, Newcastle University, Newcastle upon Tyne, United Kingdom; Aneta Mikulasova, Masaryk University, Brno, Czech Republic; and Xavier Leleu, Hôpital C. Huriez, Centre Hospitalier Régional Universitaire de Lille, Lille, France., Begum DB; Brian A. Walker, Eileen M. Boyle, Christopher P. Wardell, Alex Murison, Dil B. Begum, Nasrin M. Dahir, Paula Z. Proszek, David C. Johnson, Martin F. Kaiser, Lorenzo Melchor, Lauren I. Aronson, Charlotte Pawlyn, Fabio Mirabella, John R. Jones, Annamaria Brioli, Faith E. Davies, and Gareth J. Morgan, The Institute of Cancer Research, London; Matthew Scales, The Institute of Cancer Research, Surrey; David A. Cairns, Walter M. Gregory, and Ana Quartilho, University of Leeds; Gordon Cook, St James's University Hospital, Leeds; Mark T. Drayson, University of Birmingham, Birmingham; Nigel Russell, Nottingham University Hospital, Nottingham; Graham H. Jackson, Newcastle University, Newcastle upon Tyne, United Kingdom; Aneta Mikulasova, Masaryk University, Brno, Czech Republic; and Xavier Leleu, Hôpital C. Huriez, Centre Hospitalier Régional Universitaire de Lille, Lille, France., Dahir NM; Brian A. Walker, Eileen M. Boyle, Christopher P. Wardell, Alex Murison, Dil B. Begum, Nasrin M. Dahir, Paula Z. Proszek, David C. Johnson, Martin F. Kaiser, Lorenzo Melchor, Lauren I. Aronson, Charlotte Pawlyn, Fabio Mirabella, John R. Jones, Annamaria Brioli, Faith E. Davies, and Gareth J. Morgan, The Institute of Cancer Research, London; Matthew Scales, The Institute of Cancer Research, Surrey; David A. Cairns, Walter M. Gregory, and Ana Quartilho, University of Leeds; Gordon Cook, St James's University Hospital, Leeds; Mark T. Drayson, University of Birmingham, Birmingham; Nigel Russell, Nottingham University Hospital, Nottingham; Graham H. Jackson, Newcastle University, Newcastle upon Tyne, United Kingdom; Aneta Mikulasova, Masaryk University, Brno, Czech Republic; and Xavier Leleu, Hôpital C. Huriez, Centre Hospitalier Régional Universitaire de Lille, Lille, France., Proszek PZ; Brian A. Walker, Eileen M. Boyle, Christopher P. Wardell, Alex Murison, Dil B. Begum, Nasrin M. Dahir, Paula Z. Proszek, David C. Johnson, Martin F. Kaiser, Lorenzo Melchor, Lauren I. Aronson, Charlotte Pawlyn, Fabio Mirabella, John R. Jones, Annamaria Brioli, Faith E. Davies, and Gareth J. Morgan, The Institute of Cancer Research, London; Matthew Scales, The Institute of Cancer Research, Surrey; David A. Cairns, Walter M. Gregory, and Ana Quartilho, University of Leeds; Gordon Cook, St James's University Hospital, Leeds; Mark T. Drayson, University of Birmingham, Birmingham; Nigel Russell, Nottingham University Hospital, Nottingham; Graham H. Jackson, Newcastle University, Newcastle upon Tyne, United Kingdom; Aneta Mikulasova, Masaryk University, Brno, Czech Republic; and Xavier Leleu, Hôpital C. Huriez, Centre Hospitalier Régional Universitaire de Lille, Lille, France., Johnson DC; Brian A. Walker, Eileen M. Boyle, Christopher P. Wardell, Alex Murison, Dil B. Begum, Nasrin M. Dahir, Paula Z. Proszek, David C. Johnson, Martin F. Kaiser, Lorenzo Melchor, Lauren I. Aronson, Charlotte Pawlyn, Fabio Mirabella, John R. Jones, Annamaria Brioli, Faith E. Davies, and Gareth J. Morgan, The Institute of Cancer Research, London; Matthew Scales, The Institute of Cancer Research, Surrey; David A. Cairns, Walter M. Gregory, and Ana Quartilho, University of Leeds; Gordon Cook, St James's University Hospital, Leeds; Mark T. Drayson, University of Birmingham, Birmingham; Nigel Russell, Nottingham University Hospital, Nottingham; Graham H. Jackson, Newcastle University, Newcastle upon Tyne, United Kingdom; Aneta Mikulasova, Masaryk University, Brno, Czech Republic; and Xavier Leleu, Hôpital C. Huriez, Centre Hospitalier Régional Universitaire de Lille, Lille, France., Kaiser MF; Brian A. Walker, Eileen M. Boyle, Christopher P. Wardell, Alex Murison, Dil B. Begum, Nasrin M. Dahir, Paula Z. Proszek, David C. Johnson, Martin F. Kaiser, Lorenzo Melchor, Lauren I. Aronson, Charlotte Pawlyn, Fabio Mirabella, John R. Jones, Annamaria Brioli, Faith E. Davies, and Gareth J. Morgan, The Institute of Cancer Research, London; Matthew Scales, The Institute of Cancer Research, Surrey; David A. Cairns, Walter M. Gregory, and Ana Quartilho, University of Leeds; Gordon Cook, St James's University Hospital, Leeds; Mark T. Drayson, University of Birmingham, Birmingham; Nigel Russell, Nottingham University Hospital, Nottingham; Graham H. Jackson, Newcastle University, Newcastle upon Tyne, United Kingdom; Aneta Mikulasova, Masaryk University, Brno, Czech Republic; and Xavier Leleu, Hôpital C. Huriez, Centre Hospitalier Régional Universitaire de Lille, Lille, France., Melchor L; Brian A. Walker, Eileen M. Boyle, Christopher P. Wardell, Alex Murison, Dil B. Begum, Nasrin M. Dahir, Paula Z. Proszek, David C. Johnson, Martin F. Kaiser, Lorenzo Melchor, Lauren I. Aronson, Charlotte Pawlyn, Fabio Mirabella, John R. Jones, Annamaria Brioli, Faith E. Davies, and Gareth J. Morgan, The Institute of Cancer Research, London; Matthew Scales, The Institute of Cancer Research, Surrey; David A. Cairns, Walter M. Gregory, and Ana Quartilho, University of Leeds; Gordon Cook, St James's University Hospital, Leeds; Mark T. Drayson, University of Birmingham, Birmingham; Nigel Russell, Nottingham University Hospital, Nottingham; Graham H. Jackson, Newcastle University, Newcastle upon Tyne, United Kingdom; Aneta Mikulasova, Masaryk University, Brno, Czech Republic; and Xavier Leleu, Hôpital C. Huriez, Centre Hospitalier Régional Universitaire de Lille, Lille, France., Aronson LI; Brian A. Walker, Eileen M. Boyle, Christopher P. Wardell, Alex Murison, Dil B. Begum, Nasrin M. Dahir, Paula Z. Proszek, David C. Johnson, Martin F. Kaiser, Lorenzo Melchor, Lauren I. Aronson, Charlotte Pawlyn, Fabio Mirabella, John R. Jones, Annamaria Brioli, Faith E. Davies, and Gareth J. Morgan, The Institute of Cancer Research, London; Matthew Scales, The Institute of Cancer Research, Surrey; David A. Cairns, Walter M. Gregory, and Ana Quartilho, University of Leeds; Gordon Cook, St James's University Hospital, Leeds; Mark T. Drayson, University of Birmingham, Birmingham; Nigel Russell, Nottingham University Hospital, Nottingham; Graham H. Jackson, Newcastle University, Newcastle upon Tyne, United Kingdom; Aneta Mikulasova, Masaryk University, Brno, Czech Republic; and Xavier Leleu, Hôpital C. Huriez, Centre Hospitalier Régional Universitaire de Lille, Lille, France., Scales M; Brian A. Walker, Eileen M. Boyle, Christopher P. Wardell, Alex Murison, Dil B. Begum, Nasrin M. Dahir, Paula Z. Proszek, David C. Johnson, Martin F. Kaiser, Lorenzo Melchor, Lauren I. Aronson, Charlotte Pawlyn, Fabio Mirabella, John R. Jones, Annamaria Brioli, Faith E. Davies, and Gareth J. Morgan, The Institute of Cancer Research, London; Matthew Scales, The Institute of Cancer Research, Surrey; David A. Cairns, Walter M. Gregory, and Ana Quartilho, University of Leeds; Gordon Cook, St James's University Hospital, Leeds; Mark T. Drayson, University of Birmingham, Birmingham; Nigel Russell, Nottingham University Hospital, Nottingham; Graham H. Jackson, Newcastle University, Newcastle upon Tyne, United Kingdom; Aneta Mikulasova, Masaryk University, Brno, Czech Republic; and Xavier Leleu, Hôpital C. Huriez, Centre Hospitalier Régional Universitaire de Lille, Lille, France., Pawlyn C; Brian A. Walker, Eileen M. Boyle, Christopher P. Wardell, Alex Murison, Dil B. Begum, Nasrin M. Dahir, Paula Z. Proszek, David C. Johnson, Martin F. Kaiser, Lorenzo Melchor, Lauren I. Aronson, Charlotte Pawlyn, Fabio Mirabella, John R. Jones, Annamaria Brioli, Faith E. Davies, and Gareth J. Morgan, The Institute of Cancer Research, London; Matthew Scales, The Institute of Cancer Research, Surrey; David A. Cairns, Walter M. Gregory, and Ana Quartilho, University of Leeds; Gordon Cook, St James's University Hospital, Leeds; Mark T. Drayson, University of Birmingham, Birmingham; Nigel Russell, Nottingham University Hospital, Nottingham; Graham H. Jackson, Newcastle University, Newcastle upon Tyne, United Kingdom; Aneta Mikulasova, Masaryk University, Brno, Czech Republic; and Xavier Leleu, Hôpital C. Huriez, Centre Hospitalier Régional Universitaire de Lille, Lille, France., Mirabella F; Brian A. Walker, Eileen M. Boyle, Christopher P. Wardell, Alex Murison, Dil B. Begum, Nasrin M. Dahir, Paula Z. Proszek, David C. Johnson, Martin F. Kaiser, Lorenzo Melchor, Lauren I. Aronson, Charlotte Pawlyn, Fabio Mirabella, John R. Jones, Annamaria Brioli, Faith E. Davies, and Gareth J. Morgan, The Institute of Cancer Research, London; Matthew Scales, The Institute of Cancer Research, Surrey; David A. Cairns, Walter M. Gregory, and Ana Quartilho, University of Leeds; Gordon Cook, St James's University Hospital, Leeds; Mark T. Drayson, University of Birmingham, Birmingham; Nigel Russell, Nottingham University Hospital, Nottingham; Graham H. Jackson, Newcastle University, Newcastle upon Tyne, United Kingdom; Aneta Mikulasova, Masaryk University, Brno, Czech Republic; and Xavier Leleu, Hôpital C. Huriez, Centre Hospitalier Régional Universitaire de Lille, Lille, France., Jones JR; Brian A. Walker, Eileen M. Boyle, Christopher P. Wardell, Alex Murison, Dil B. Begum, Nasrin M. Dahir, Paula Z. Proszek, David C. Johnson, Martin F. Kaiser, Lorenzo Melchor, Lauren I. Aronson, Charlotte Pawlyn, Fabio Mirabella, John R. Jones, Annamaria Brioli, Faith E. Davies, and Gareth J. Morgan, The Institute of Cancer Research, London; Matthew Scales, The Institute of Cancer Research, Surrey; David A. Cairns, Walter M. Gregory, and Ana Quartilho, University of Leeds; Gordon Cook, St James's University Hospital, Leeds; Mark T. Drayson, University of Birmingham, Birmingham; Nigel Russell, Nottingham University Hospital, Nottingham; Graham H. Jackson, Newcastle University, Newcastle upon Tyne, United Kingdom; Aneta Mikulasova, Masaryk University, Brno, Czech Republic; and Xavier Leleu, Hôpital C. Huriez, Centre Hospitalier Régional Universitaire de Lille, Lille, France., Brioli A; Brian A. Walker, Eileen M. Boyle, Christopher P. Wardell, Alex Murison, Dil B. Begum, Nasrin M. Dahir, Paula Z. Proszek, David C. Johnson, Martin F. Kaiser, Lorenzo Melchor, Lauren I. Aronson, Charlotte Pawlyn, Fabio Mirabella, John R. Jones, Annamaria Brioli, Faith E. Davies, and Gareth J. Morgan, The Institute of Cancer Research, London; Matthew Scales, The Institute of Cancer Research, Surrey; David A. Cairns, Walter M. Gregory, and Ana Quartilho, University of Leeds; Gordon Cook, St James's University Hospital, Leeds; Mark T. Drayson, University of Birmingham, Birmingham; Nigel Russell, Nottingham University Hospital, Nottingham; Graham H. Jackson, Newcastle University, Newcastle upon Tyne, United Kingdom; Aneta Mikulasova, Masaryk University, Brno, Czech Republic; and Xavier Leleu, Hôpital C. Huriez, Centre Hospitalier Régional Universitaire de Lille, Lille, France., Mikulasova A; Brian A. Walker, Eileen M. Boyle, Christopher P. Wardell, Alex Murison, Dil B. Begum, Nasrin M. Dahir, Paula Z. Proszek, David C. Johnson, Martin F. Kaiser, Lorenzo Melchor, Lauren I. Aronson, Charlotte Pawlyn, Fabio Mirabella, John R. Jones, Annamaria Brioli, Faith E. Davies, and Gareth J. Morgan, The Institute of Cancer Research, London; Matthew Scales, The Institute of Cancer Research, Surrey; David A. Cairns, Walter M. Gregory, and Ana Quartilho, University of Leeds; Gordon Cook, St James's University Hospital, Leeds; Mark T. Drayson, University of Birmingham, Birmingham; Nigel Russell, Nottingham University Hospital, Nottingham; Graham H. Jackson, Newcastle University, Newcastle upon Tyne, United Kingdom; Aneta Mikulasova, Masaryk University, Brno, Czech Republic; and Xavier Leleu, Hôpital C. Huriez, Centre Hospitalier Régional Universitaire de Lille, Lille, France., Cairns DA; Brian A. Walker, Eileen M. Boyle, Christopher P. Wardell, Alex Murison, Dil B. Begum, Nasrin M. Dahir, Paula Z. Proszek, David C. Johnson, Martin F. Kaiser, Lorenzo Melchor, Lauren I. Aronson, Charlotte Pawlyn, Fabio Mirabella, John R. Jones, Annamaria Brioli, Faith E. Davies, and Gareth J. Morgan, The Institute of Cancer Research, London; Matthew Scales, The Institute of Cancer Research, Surrey; David A. Cairns, Walter M. Gregory, and Ana Quartilho, University of Leeds; Gordon Cook, St James's University Hospital, Leeds; Mark T. Drayson, University of Birmingham, Birmingham; Nigel Russell, Nottingham University Hospital, Nottingham; Graham H. Jackson, Newcastle University, Newcastle upon Tyne, United Kingdom; Aneta Mikulasova, Masaryk University, Brno, Czech Republic; and Xavier Leleu, Hôpital C. Huriez, Centre Hospitalier Régional Universitaire de Lille, Lille, France., Gregory WM; Brian A. Walker, Eileen M. Boyle, Christopher P. Wardell, Alex Murison, Dil B. Begum, Nasrin M. Dahir, Paula Z. Proszek, David C. Johnson, Martin F. Kaiser, Lorenzo Melchor, Lauren I. Aronson, Charlotte Pawlyn, Fabio Mirabella, John R. Jones, Annamaria Brioli, Faith E. Davies, and Gareth J. Morgan, The Institute of Cancer Research, London; Matthew Scales, The Institute of Cancer Research, Surrey; David A. Cairns, Walter M. Gregory, and Ana Quartilho, University of Leeds; Gordon Cook, St James's University Hospital, Leeds; Mark T. Drayson, University of Birmingham, Birmingham; Nigel Russell, Nottingham University Hospital, Nottingham; Graham H. Jackson, Newcastle University, Newcastle upon Tyne, United Kingdom; Aneta Mikulasova, Masaryk University, Brno, Czech Republic; and Xavier Leleu, Hôpital C. Huriez, Centre Hospitalier Régional Universitaire de Lille, Lille, France., Quartilho A; Brian A. Walker, Eileen M. Boyle, Christopher P. Wardell, Alex Murison, Dil B. Begum, Nasrin M. Dahir, Paula Z. Proszek, David C. Johnson, Martin F. Kaiser, Lorenzo Melchor, Lauren I. Aronson, Charlotte Pawlyn, Fabio Mirabella, John R. Jones, Annamaria Brioli, Faith E. Davies, and Gareth J. Morgan, The Institute of Cancer Research, London; Matthew Scales, The Institute of Cancer Research, Surrey; David A. Cairns, Walter M. Gregory, and Ana Quartilho, University of Leeds; Gordon Cook, St James's University Hospital, Leeds; Mark T. Drayson, University of Birmingham, Birmingham; Nigel Russell, Nottingham University Hospital, Nottingham; Graham H. Jackson, Newcastle University, Newcastle upon Tyne, United Kingdom; Aneta Mikulasova, Masaryk University, Brno, Czech Republic; and Xavier Leleu, Hôpital C. Huriez, Centre Hospitalier Régional Universitaire de Lille, Lille, France., Drayson MT; Brian A. Walker, Eileen M. Boyle, Christopher P. Wardell, Alex Murison, Dil B. Begum, Nasrin M. Dahir, Paula Z. Proszek, David C. Johnson, Martin F. Kaiser, Lorenzo Melchor, Lauren I. Aronson, Charlotte Pawlyn, Fabio Mirabella, John R. Jones, Annamaria Brioli, Faith E. Davies, and Gareth J. Morgan, The Institute of Cancer Research, London; Matthew Scales, The Institute of Cancer Research, Surrey; David A. Cairns, Walter M. Gregory, and Ana Quartilho, University of Leeds; Gordon Cook, St James's University Hospital, Leeds; Mark T. Drayson, University of Birmingham, Birmingham; Nigel Russell, Nottingham University Hospital, Nottingham; Graham H. Jackson, Newcastle University, Newcastle upon Tyne, United Kingdom; Aneta Mikulasova, Masaryk University, Brno, Czech Republic; and Xavier Leleu, Hôpital C. Huriez, Centre Hospitalier Régional Universitaire de Lille, Lille, France., Russell N; Brian A. Walker, Eileen M. Boyle, Christopher P. Wardell, Alex Murison, Dil B. Begum, Nasrin M. Dahir, Paula Z. Proszek, David C. Johnson, Martin F. Kaiser, Lorenzo Melchor, Lauren I. Aronson, Charlotte Pawlyn, Fabio Mirabella, John R. Jones, Annamaria Brioli, Faith E. Davies, and Gareth J. Morgan, The Institute of Cancer Research, London; Matthew Scales, The Institute of Cancer Research, Surrey; David A. Cairns, Walter M. Gregory, and Ana Quartilho, University of Leeds; Gordon Cook, St James's University Hospital, Leeds; Mark T. Drayson, University of Birmingham, Birmingham; Nigel Russell, Nottingham University Hospital, Nottingham; Graham H. Jackson, Newcastle University, Newcastle upon Tyne, United Kingdom; Aneta Mikulasova, Masaryk University, Brno, Czech Republic; and Xavier Leleu, Hôpital C. Huriez, Centre Hospitalier Régional Universitaire de Lille, Lille, France., Cook G; Brian A. Walker, Eileen M. Boyle, Christopher P. Wardell, Alex Murison, Dil B. Begum, Nasrin M. Dahir, Paula Z. Proszek, David C. Johnson, Martin F. Kaiser, Lorenzo Melchor, Lauren I. Aronson, Charlotte Pawlyn, Fabio Mirabella, John R. Jones, Annamaria Brioli, Faith E. Davies, and Gareth J. Morgan, The Institute of Cancer Research, London; Matthew Scales, The Institute of Cancer Research, Surrey; David A. Cairns, Walter M. Gregory, and Ana Quartilho, University of Leeds; Gordon Cook, St James's University Hospital, Leeds; Mark T. Drayson, University of Birmingham, Birmingham; Nigel Russell, Nottingham University Hospital, Nottingham; Graham H. Jackson, Newcastle University, Newcastle upon Tyne, United Kingdom; Aneta Mikulasova, Masaryk University, Brno, Czech Republic; and Xavier Leleu, Hôpital C. Huriez, Centre Hospitalier Régional Universitaire de Lille, Lille, France., Jackson GH; Brian A. Walker, Eileen M. Boyle, Christopher P. Wardell, Alex Murison, Dil B. Begum, Nasrin M. Dahir, Paula Z. Proszek, David C. Johnson, Martin F. Kaiser, Lorenzo Melchor, Lauren I. Aronson, Charlotte Pawlyn, Fabio Mirabella, John R. Jones, Annamaria Brioli, Faith E. Davies, and Gareth J. Morgan, The Institute of Cancer Research, London; Matthew Scales, The Institute of Cancer Research, Surrey; David A. Cairns, Walter M. Gregory, and Ana Quartilho, University of Leeds; Gordon Cook, St James's University Hospital, Leeds; Mark T. Drayson, University of Birmingham, Birmingham; Nigel Russell, Nottingham University Hospital, Nottingham; Graham H. Jackson, Newcastle University, Newcastle upon Tyne, United Kingdom; Aneta Mikulasova, Masaryk University, Brno, Czech Republic; and Xavier Leleu, Hôpital C. Huriez, Centre Hospitalier Régional Universitaire de Lille, Lille, France., Leleu X; Brian A. Walker, Eileen M. Boyle, Christopher P. Wardell, Alex Murison, Dil B. Begum, Nasrin M. Dahir, Paula Z. Proszek, David C. Johnson, Martin F. Kaiser, Lorenzo Melchor, Lauren I. Aronson, Charlotte Pawlyn, Fabio Mirabella, John R. Jones, Annamaria Brioli, Faith E. Davies, and Gareth J. Morgan, The Institute of Cancer Research, London; Matthew Scales, The Institute of Cancer Research, Surrey; David A. Cairns, Walter M. Gregory, and Ana Quartilho, University of Leeds; Gordon Cook, St James's University Hospital, Leeds; Mark T. Drayson, University of Birmingham, Birmingham; Nigel Russell, Nottingham University Hospital, Nottingham; Graham H. Jackson, Newcastle University, Newcastle upon Tyne, United Kingdom; Aneta Mikulasova, Masaryk University, Brno, Czech Republic; and Xavier Leleu, Hôpital C. Huriez, Centre Hospitalier Régional Universitaire de Lille, Lille, France., Davies FE; Brian A. Walker, Eileen M. Boyle, Christopher P. Wardell, Alex Murison, Dil B. Begum, Nasrin M. Dahir, Paula Z. Proszek, David C. Johnson, Martin F. Kaiser, Lorenzo Melchor, Lauren I. Aronson, Charlotte Pawlyn, Fabio Mirabella, John R. Jones, Annamaria Brioli, Faith E. Davies, and Gareth J. Morgan, The Institute of Cancer Research, London; Matthew Scales, The Institute of Cancer Research, Surrey; David A. Cairns, Walter M. Gregory, and Ana Quartilho, University of Leeds; Gordon Cook, St James's University Hospital, Leeds; Mark T. Drayson, University of Birmingham, Birmingham; Nigel Russell, Nottingham University Hospital, Nottingham; Graham H. Jackson, Newcastle University, Newcastle upon Tyne, United Kingdom; Aneta Mikulasova, Masaryk University, Brno, Czech Republic; and Xavier Leleu, Hôpital C. Huriez, Centre Hospitalier Régional Universitaire de Lille, Lille, France., Morgan GJ; Brian A. Walker, Eileen M. Boyle, Christopher P. Wardell, Alex Murison, Dil B. Begum, Nasrin M. Dahir, Paula Z. Proszek, David C. Johnson, Martin F. Kaiser, Lorenzo Melchor, Lauren I. Aronson, Charlotte Pawlyn, Fabio Mirabella, John R. Jones, Annamaria Brioli, Faith E. Davies, and Gareth J. Morgan, The Institute of Cancer Research, London; Matthew Scales, The Institute of Cancer Research, Surrey; David A. Cairns, Walter M. Gregory, and Ana Quartilho, University of Leeds; Gordon Cook, St James's University Hospital, Leeds; Mark T. Drayson, University of Birmingham, Birmingham; Nigel Russell, Nottingham University Hospital, Nottingham; Graham H. Jackson, Newcastle University, Newcastle upon Tyne, United Kingdom; Aneta Mikulasova, Masaryk University, Brno, Czech Republic; and Xavier Leleu, Hôpital C. Huriez, Centre Hospitalier Régional Universitaire de Lille, Lille, France. gareth.morgan@icr.ac.uk.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2015 Nov 20; Vol. 33 (33), pp. 3911-20. Date of Electronic Publication: 2015 Aug 17.